Disease Burden and Health-Related Quality of Life (HRQoL) of Chronic Obstructive Pulmonary Disease (COPD) in the US – Evidence from the Medical Expenditure Panel Survey (MEPS) from 2016-2019

References

• World Health Organization. COPD fact sheet; 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed July 22, 2022.
   Google Scholar
• Criner RN, Han MK. COPD care in the 21st century: a public health priority. Respir Care. 2018;63(5):591–600. doi:10.4187/respcare.06276
   PubMed Web of Science ®Google Scholar
• Murphy SL, Kochanek KD, Xu J, Arias E. Mortality in the United States, 2020. NCHS Data Brief No. 427; 2021. Available from: https://www.cdc.gov/nchs/products/databriefs/db427.htm. Accessed August 19, 2022.
   Google Scholar
• Mannino DM, Roberts MH, Mapel DW, et al. A real-world study assessing the medical cost burden of chronic obstructive pulmonary disease (COPD) in the United States from 2016–2019 and projections through 2029: analysis of Medical Expenditure Panel Survey (MEPS) data. Am J Respir Crit Care Med. 2023; 207:A6412.
   Web of Science ®Google Scholar
• Patel JG, Coutinho AD, Lunacsek OE, Dalal AA. COPD affects worker productivity and health care costs. Int J Chron Obstruct Pulmon Dis. 2018;13:2301–2311. doi:10.2147/COPD.S163795
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults—United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(46):938–943.
   PubMedGoogle Scholar
• Murphy TE, McAvay GJ, Allore HG, Stamm JA, Simonelli PF. Contributions of COPD, asthma, and ten comorbid conditions to health care utilization and patient-centered outcomes among US adults with obstructive airway disease. Int J Chron Obstruct Pulmon Dis. 2017;12:2515–2522. doi:10.2147/COPD.S139948
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971-2000. MMWR Surveill Summ. 2002;51(6):1–16.
   Google Scholar
• Sarrazin MV, Cannon KT, Rosenthal GE, Kaldjian LC. Racial differences in mortality among veterans hospitalized for exacerbation of chronic obstructive pulmonary disease. J Natl Med Assoc. 2009;101(7):656–662. doi:10.1016/s0027-9684(15)30974-3
   PubMed Web of Science ®Google Scholar
• Eisner MD, Blanc PD, Omachi TA, et al. Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health. 2011;65(1):26–34. doi:10.1136/jech.2009.089722
   PubMed Web of Science ®Google Scholar
• Decramer M, Rennard S, Troosters T, et al. COPD as a lung disease with systemic consequences—clinical impact, mechanisms, and potential for early intervention. COPD. 2008;5(4):235–256. doi:10.1080/15412550802237531
   PubMedGoogle Scholar
• Raherison C, Ouaalaya EH, Bernady A, et al. Comorbidities and COPD severity in a clinic-based cohort. BMC Pulm Med. 2018;18(1):117. doi:10.1186/s12890-018-0684-7
   PubMedGoogle Scholar
• Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091–1097. doi:10.1378/chest.09-2029
   PubMed Web of Science ®Google Scholar
• Hu WP, Lhamo T, Zhang FY, et al. Predictors of acute cardiovascular events following acute exacerbation period for patients with COPD: a nested case-control study. BMC Cardiovasc Disord. 2020;20(1):518. doi:10.1186/s12872-020-01803-8
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.00133805
   PubMed Web of Science ®Google Scholar
• André S, Conde B, Fragoso E, Boléo-Tomé JP, Areias V, Cardoso J. GI DPOC-Grupo de Interesse na Doença Pulmonar Obstrutiva Crónica. COPD and cardiovascular disease. Pulmonology. 2019;25(3):168–176. PMID: 30527374. doi:10.1016/j.pulmoe.2018.09.006
   PubMed Web of Science ®Google Scholar
• Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD. 2010;7(5):375–382. PMID: 20854053; PMCID: PMC7273182. doi:10.3109/15412555.2010.510160
   PubMedGoogle Scholar
• Dalal AA, Patel J, D’Souza A, Farrelly E, Nagar S, Shah M. Impact of COPD exacerbation frequency on costs for a managed care population. J Manag Care Spec Pharm. 2015;21(7):575–583. doi:10.18553/jmcp.2015.21.7.575
   PubMed Web of Science ®Google Scholar
• Dhamane AD, Witt EA, Su J. Associations between COPD severity and work productivity, health-related quality of life, and health care resource use: a cross-sectional analysis of national survey data. J Occup Environ Med. 2016;58(6):e191–e197. doi:10.1097/JOM.0000000000000735
   PubMed Web of Science ®Google Scholar
• DiBonaventura MD, Paulose-Ram R, Su J, et al. The burden of chronic obstructive pulmonary disease among employed adults. Int J Chron Obstruct Pulmon Dis. 2012;7:211–219. doi:10.2147/COPD.S29280
   PubMed Web of Science ®Google Scholar
• Jacobs DM, Noyes K, Zhao J, et al. Early hospital readmissions after an acute exacerbation of chronic obstructive pulmonary disease in the Nationwide Readmissions Database. Ann Am Thorac Soc. 2018;15(7):837–845. doi:10.1513/AnnalsATS.201712-913OC
   PubMed Web of Science ®Google Scholar
• Ejike CO, Woo H, Galiatsatos P, et al. Contribution of individual and neighborhood factors to racial disparities in respiratory outcomes. Am J Respir Crit Care Med. 2021;203(8):987–997. doi:10.1164/rccm.202002-0253OC
   PubMed Web of Science ®Google Scholar
• Stellefson M, Wang MQ, Kinder C. Racial disparities in health risk indicators reported by Alabamians diagnosed with COPD. Int J Environ Res Public Health. 2021;18(18):9662. doi:10.3390/ijerph18189662
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality (AHRQ). MEPS General FAQs. Available from: https://meps.ahrq.gov/communication/participants/faq_gen_mpc.shtml#FAQ10. Accessed September 12, 2023.
   Google Scholar
• Office for Human Research Protections (OHRP). 45 CFR 46 Exemptions (2018 Requirements); 2021. Available from: https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html. Accessed September 12, 2023.
   Google Scholar
• Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. Chest. 2015;147(1):31–45. doi:10.1378/chest.14-0972
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality (AHRQ). Using appropriate price indices for analyses of health care expenditures or income across multiple years; 2023. Available from: https://meps.ahrq.gov/about_meps/Price_Index.shtml. Accessed September 12, 2023.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of COPD: 2024 Report; 2023. Available from: https://goldcopd.org/2024-gold-report/. Accessed January 30, 2024.
   Google Scholar
• Roberts MH, Mapel DW, Hartry A, Von Worley A, Thomson H. Chronic pain and pain medication use in chronic obstructive pulmonary disease. A cross-sectional study. Ann Am Thorac Soc. 2013;10(4):290–298. doi:10.1513/AnnalsATS.201303-040OC
   PubMedGoogle Scholar
• Lee AL, Goldstein RS, Brooks D. Chronic pain in people with chronic obstructive pulmonary disease: prevalence, clinical and psychological implications. Chronic Obstr Pulm Dis. 2017;4(3):194–203. doi:10.15326/jcopdf.4.3.2016.0172
   PubMed Web of Science ®Google Scholar
• Garvey C, Bayles MP, Hamm LF, et al. Pulmonary rehabilitation exercise prescription in chronic obstructive pulmonary disease: review of selected guidelines: an official statement from the American association of cardiovascular and pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2016;36(2):75–83. doi:10.1097/HCR.0000000000000171
   PubMed Web of Science ®Google Scholar
• Marengoni A, Vetrano DL, Manes-Gravina E, Bernabei R, Onder G, Palmer K. The relationship between COPD and frailty: a systematic review and meta-analysis of observational studies. Chest. 2018;154(1):21–40. doi:10.1016/j.chest.2018.02.014
   PubMed Web of Science ®Google Scholar
• Nolan CM, Longworth L, Lord J, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016;71(6):493–500. doi:10.1136/thoraxjnl-2015-207782
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. doi:10.1183/09031936.00128008
   PubMed Web of Science ®Google Scholar
• Boschetto P, Beghé B, Fabbri LM, Ceconi C. Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice. Respirology. 2012;17(3):422–431. doi:10.1111/j.1440-1843.2011.02118.x
   PubMed Web of Science ®Google Scholar
• Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639. doi:10.1016/S2213-2600(15)00241-6
   PubMed Web of Science ®Google Scholar
• Müllerová H, Marshall J, de Nigris E, et al. Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis. Ther Adv Respir Dis. 2022;16:17534666221113647. doi:10.1177/17534666221113647
   Google Scholar
• Afroz N, Gutzwiller FS, Mackay AJ, Naujoks C, Patalano F, Kostikas K. Patient-reported outcomes (PROs) in COPD clinical trials: trends and gaps. Int J Chron Obstruct Pulmon Dis. 2020;15:1789–1800. doi:10.2147/COPD.S235845
   PubMed Web of Science ®Google Scholar
• Dhamane AD, Moretz C, Zhou Y, et al. COPD exacerbation frequency and its association with health care resource utilization and costs. Int J Chron Obstruct Pulmon Dis. 2015;10:2609–2618. doi:10.2147/COPD.S90148
   PubMed Web of Science ®Google Scholar
• Vaz Fragoso CA, Murphy TE, Agogo GO, Allore HG, McAvay GJ. Asthma-COPD overlap syndrome in the US: a prospective population-based analysis of patient-reported outcomes and health care utilization. Int J Chron Obstruct Pulmon Dis. 2017;12:517–527. doi:10.2147/COPD.S121223
   PubMed Web of Science ®Google Scholar
• Schiltz NK. Prevalence of multimorbidity combinations and their association with medical costs and poor health: a population-based study of U.S. adults. Front Public Health. 2022;10:953886. doi:10.3389/fpubh.2022.953886
   PubMed Web of Science ®Google Scholar
• Lee AL, Harrison SL, Goldstein RS, Brooks D. Pain and its clinical associations in individuals with COPD: a systematic review. Chest. 2015;147(5):1246–1258. doi:10.1378/chest.14-2690
   PubMed Web of Science ®Google Scholar